NEOMYCIN SULFATE Tablet
Labeling: Label Mixup; NEOMYCIN SULFATE, Tablet, 500 mg may be potentially mislabeled as IMIPRAMINE HCL, Tablet, 25 mg, NDC 00781176401, Pedigree: AD49448_10, EXP: 5/17/2014.
Yes — there is an active recall. 9 ongoing FDA recalls mention Neomycin (28 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Neomycin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Labeling: Label Mixup; NEOMYCIN SULFATE, Tablet, 500 mg may be potentially mislabeled as IMIPRAMINE HCL, Tablet, 25 mg, NDC 00781176401, Pedigree: AD49448_10, EXP: 5/17/2014.
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Failed Stability Specifications: Unable to meet shelf life expiry.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.